The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: etoposide     Quarter: 2016Q3

Total Records: 893     Number of Pages: 45

DRUGNAME PT EventCount
ETOPOSIDE (Manufacturer Unknown) Asthenia 3
ETOPOSIDE (Manufacturer Unknown) Blood creatinine abnormal 3
ETOPOSIDE (Manufacturer Unknown) Fatigue 3
ETOPOSIDE (Manufacturer Unknown) Hyperadrenocorticism 3
ETOPOSIDE (Manufacturer Unknown) Hypomagnesaemia 3
ETOPOSIDE (Manufacturer Unknown) Rash 3
ETOPOSIDE (Manufacturer Unknown) Renal disorder 3
ETOPOSIDE (VP-16) Abdominal pain 3
ETOPOSIDE (VP-16) Apnoea 3
ETOPOSIDE (VP-16) Blood culture positive 3
ETOPOSIDE (VP-16) Blood pressure decreased 3
ETOPOSIDE (VP-16) Chills 3
ETOPOSIDE (VP-16) Decreased appetite 3
ETOPOSIDE (VP-16) Feeling abnormal 3
ETOPOSIDE (VP-16) Generalised tonic-clonic seizure 3
ETOPOSIDE (VP-16) Hypotension 3
ETOPOSIDE (VP-16) Loss of consciousness 3
ETOPOSIDE (VP-16) Necrotising fasciitis 3
ETOPOSIDE (VP-16) Pain 3
ETOPOSIDE (VP-16) Pallor 3

Total Records: 893     Number of Pages: 45